menu
    • menu

    Company profile for XWPharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company dedicated to the discovery and development of therapeutics applying novel platform chemistry to time-regulated neurobiology. XWPharma employs the following strategies across all of our programs to increase the odds that our internally discovered medicines will succeed in clinical testing and commercialization. We focus our propriety drug discovery methodology on mechanisms of ...
    We are a clinical stage biopharmaceutical company dedicated to the discovery and development of therapeutics applying novel platform chemistry to time-regulated neurobiology. XWPharma employs the following strategies across all of our programs to increase the odds that our internally discovered medicines will succeed in clinical testing and commercialization. We focus our propriety drug discovery methodology on mechanisms of action that are validated as highly effective in clinical studies and medical practice. Our investigational drug therapies aim to leverage time-regulated neurobiology to achieve efficacy without the limitations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XWPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3 Lagoon Drive Ste 160 Redwood City, CA 94065
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xwpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xwlabs
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kerry Corning starts trial of XW10508 for refractory depression & chronic pain
    Kerry Corning starts trial of XW10508 for refractory depression & chronic pain

    08 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/08/2293324/0/zh-hans/%E5%87%AF%E7%91%9E%E5%BA%B7%E5%AE%81%E5%90%AF%E5%8A%A8-XW10508%E9%A6%96%E6%AC%A1%E4%BA%BA%E4%BD%93%E8%AF%95%E9%AA%8C-%E5%BC%80%E5%8F%91%E5%BF%AB%E9%80%9F%E7%BC%93%E8%A7%A3%E9%9A%BE%E6%B2%BB%E6%80%A7%E6%8A%91%E9%83%81%E7%97%87%E5%92%8C%E6%85%A2%E6%80%A7%E7%96%BC%E7%97%9B%E7%9A%84%E8%8D%AF%E7%89%A9.html

    GLOBENEWSWIRE
    08 Sep 2021
    Share Share
    XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172
    XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172

    14 Jun 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/xwpharma-announces-positive-results-from-phase-1-clinical-trials-of-xw10172-in-development-as-once-nightly-therapy-for-sleep-disorders-in-patients-with-neurodegenerative-diseases/

    BIOSPACE
    14 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search